BBOT
BridgeBio Oncology Therapeutics, Inc.
3.60$
-7.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 22 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -0.38 | 0.00 | -1.67 | -4.80 | -1.81 | -464.02 | -1.62 | -0.53 | -448.78 | -554.14 | -2,412.60 | |
| – | – | 0.00 | 0.00 | 0.01 | 2.84 | 0.13 | 3.61 | 0.01 | 0.00 | 2.32 | 0.95 | 10.89 | |
| – | – | 0.07 | 0.00 | 0.00 | 4.23 | 0.14 | 17.43 | 0.07 | 0.04 | 48.37 | 90.28 | 210.82 | |
| – | – | 0.21 | 0.01 | 0.49 | 6.96 | 0.05 | 89.15 | 0.24 | -0.08 | 27.56 | 119.83 | 196.44 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.55 | 0.40 | 4.60 | 0.01 | 0.00 | 0.30 | 0.59 | 8.46 | |
| – | – | 0.10 | – | 1.61 | – | – | 192.02 | 1.51 | 0.10 | -3,566.16 | 571.23 | -2,077.97 | |
| – | – | 0.28 | 8.49 | 0.84 | 2.84 | -0.99 | 377.62 | 8.83 | -0.01 | 3.69 | 0.46 | 4,793.44 | |
| – | – | 0.01 | 0.00 | 0.00 | -4.80 | -1.81 | 105.62 | 9.38 | -0.44 | -4,011.26 | 17.55 | 667.03 | |
| – | – | -0.38 | 0.00 | -1.68 | -4.80 | -1.81 | -468.62 | -1.64 | -0.53 | -449.08 | -554.73 | -2,421.06 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.